Interactions of manufactured silver nanoparticles of different sizes with normal human dermal fibroblasts

International Wound Journal

Volumn 13, Issue 1, 2016, Pages 101-109

  Avalos, Alicia ^a   Haza, Ana I ^a   Mateo, Diego ^a   Morales, Paloma ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cytotoxicity; Normal human dermal fibroblasts; Reactive oxygen species; Silver nanoparticles

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SUPEROXIDE DISMUTASE; ANTIOXIDANT; COLORING AGENT; LACTATE DEHYDROGENASE; METAL NANOPARTICLE; SILVER DERIVATIVE; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; SKIN FIBROBLAST; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; METABOLISM; SKIN;

ACETYLCYSTEINE; ANTIOXIDANTS; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; FIBROBLASTS; GLUTATHIONE; HUMANS; L-LACTATE DEHYDROGENASE; METAL NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILVER COMPOUNDS; SKIN; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84955688125     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/iwj.12244     Document Type: Article

References (58)

1. Hoyt VW, Mason E. Nanotechnology: emerging health issues. J Chem Health Saf 2008;15:10-5.
2. Chairuangkitti P, Lawanprasert S, Roytrakul S, Aueviriyavit S, Phummiratch D, Kulthong K, Chanvorachote P, Maniratanachote R. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol In Vitro 2013;27:330-8.
3. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. Toxicity of silver nanoparticles - nanoparticle or silver ion? Toxicol Lett 2012;208:286-92.
4. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Walker NJ, Warheit DB. Safe handling in nanotechnology. Nature 2006;444:267-9.
5. Castranova V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med 2011;53:14-7.
6. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF. Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010;2:544-68.
7. Xia T, Kovochich M, Nel AE. Impairment of mitochondrial function by particle matter (PM) and their toxic components: implications for PM-induced cardiovascular and lung disease. Front Biosci 2007;12:1238-46.
8. EFSA Scientific Committee. Guidance on the risk assessment of the application of nanoscience and nanotechnologies in the food and feed chain. EFSA Journal 2011;9:2140.
9. Henig RM. Our silver-coated future. OnEarth 2007;23-9.
10. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RHJ. Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol 2007;7:1893-7.
11. Samuel U, Guggenbichler JP. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 2004;23:75-8.
12. Gosheger G, Hardes J, Ahrens H, Streitburger A, Buerger H, Erren M, Gunsel A, Kemper FH, Winkelmann W, Von EC. Silver-coated megaendoprostheses in a rabbit model-an analysis of the infection rate and toxicological side effects. Biomaterials 2004;25:5547-56.
13. Margaret IP, Sau LL, Vincent KMP, Ivan L, Andrew B. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 2006;55:59-63.
14. Larese FF, D'Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 2009;255:33-7.
15. Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006;60:648-52.
16. Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006;117:110-8.
17. Lam PK, Chan ES, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline silver dressing (acticoat) on cultured keratinocytes. Br J Biomed Sci 2004;61:125-7.
18. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005;19:975-83.
19. Hussain S, Javorina A, Schrand A, Duhart H, Ali S, Schlager J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006;92(Suppl 2):456-63.
20. Park S, Lee YK, Jung M, Kim KH, Chung N, Ahn EK, Lim Y, Lee KH. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol 2007;19(Suppl 1):59-65.
21. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian stem cells. Toxicol Sci 2005;88:412-9.
22. Kim S, Choi JE, Choi J, Chung K, Park K, Yi J, Ryu D. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 2009;23:1076-84.
23. Ahamed M, Siddiqui MKJ. Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta 2007;383:57-64.
24. Hidalgo E, Bartolome R, Barroso C, Moreno A, Dominguez C. Silver nitrate: antimicrobial activity related to cytotoxicity in cultured human fibroblasts. Skin Pharmacol Appl Skin Physiol 1998;11:140-51.
25. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010;40:328-46.
26. Ávalos A, Haza AI, Mateo D, Morales P. Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells. J Appl Toxicol 2013. DOI: 10.1002/jat.2957.
27. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 2008;101:239-53.
28. García A, Morales P, Arranz N, Delgado E, Rafter J, Haza AI. Induction of apoptosis and reactive oxygen species production by N-nitrosopiperidine and N-nitrosodibutylamine in human leukemia cells. J Appl Toxicol 2008;28:455-65.
29. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science 2006;311:622-7.
30. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003;60:6-20.
31. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. The apoptotic effect of nanosilver is mediated by ROS- and JNK dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett 2008;179:130-9.
32. Fauss E. The silver nanotechnology commercial inventory. Virginia Univ, 2008.
33. Hunt TK, Hopt HW. Wound healing and infection, what surgeons and anesthesiologist can do? Surg Clin North Am 1997;77:587-606.
34. Oberdörster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder ACP. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 2000;96:5-74.
35. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA. Nanotoxicology. Occup Environ Med 2004;61:727-8.
36. Skebo JE, Grabinski CM, Schrand AM, Schlager JJ, Hussain SM. Assessment of metal nanoparticle agglomeration, uptake, and interaction using high-illuminating system. Int J Toxicol 2007;26:135-41.
37. Liu S, Wei L, Hao L, Fang N, Chang MW, Xu R, Yang Y, Chen Y. Sharper and faster "nano darts" kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano 2009;3:3891-902.
38. Lynch I, Dawson K. Protein-nanoparticle interactions. Nanotoday 2008;3:40-7.
39. Lundqvist M, Stigler J, Elia G, Lynch I, Cerdevall T, Dawson K. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008;105:14265-70.
40. Kato H. In vitro assays: tracking nanoparticles inside cells. Nat Nanotechnol 2011;6:139-40.
41. Arora S, Jain J, Rajwade JM, Paknikar KM. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol Appl Pharmacol 2009;236:310-8.
42. Park MV, Neigh AM, Vermeulen JP, Fonteyne LJJ, Verharen HW, Briedé JJ, Loveren HV, Jong WH. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011;32:9810-7.
43. Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 2008;179:93-100.
44. Asharani PV, Grace LKM, Manoor PH, Suresh V. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;3:279-90.
45. Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, Ryu G, Myung H. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol Lett 2008;30:1893-9.
46. Powers CM, Badireddy AR, Ryde IT, Seidler FJ, Slotkin TA. Silver nanoparticles compromise neurodevelopment in PC12 cells: critical contributions of silver ion, particle size, coating, and composition. Environ Health Perspect 2011;119:37-44.
47. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008;29:1912-9.
48. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Colloids Surf B Biointerfaces 2008;65:1-10.
49. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake by mammalian cells. Nano Lett 2006;6:662-8.
50. Jin CY, Zhu BS, Wang XF, Lu QH. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 2008;21:1871-7.
51. Colvin VL. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 2003;21:1166-70.
52. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006;6:1794-807.
53. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009;190:156-62.
54. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. Unique cellular interaction of silver nanoparticles: size dependent generation of reactive oxygen species. J Phys Chem B 2008;112:13608-19.
55. Anderson MF, Nilsson M, Eriksson PS, Sims NR. Glutathione monoethyl ester provides neuroprotection in a rat model of stroke. Neurosci Lett 2004;354:163-5.
56. Dewarijee S, Maiti A, Sahu R, Dua TK, Mandal V. Effective control of type 2 diabetes through antioxidant defense by edible fruits of Diospyros peregrina. Evid Based Complement Alternat Med 2011;2009:1-7.
57. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999;27:916-21.
58. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011;201:92-100.